Liver, Pancreatic Cancer Specialist Joins Wilmot Cancer Center

Aug. 4, 2009

Hepatobiliary oncologist Aram Hezel, M.D., has joined the University of Rochester Medical Center’s James P. Wilmot Cancer Center. He relocated from Massachusetts General Hospital Cancer Center and Harvard Medical School in Boston.
Hezel, an assistant professor of Medicine, will join the Gastrointestinal Oncology Team at the Wilmot Cancer Center where he will focus on the research and treatment of pancreatic and liver cancers. He will also develop a multidisciplinary clinic with the liver transplant team. Together these cancers affect about 65,000 people each year in the United States.
He has studied the genetics of pancreatic and biliary tract cancers and tested novel treatments in preclinical settings. His research, including clinical trials in pancreatic and hepatobiliary cancers, is published in oncology and science journals.
Hezel is a graduate of Vassar College and studied at SUNY Buffalo School of Medicine. He completed residency in internal medicine at Beth Israel Deaconess Medical Center followed by a Fellowship in medical oncology at Dana-Farber Cancer Institute. He was on staff at Massachusetts General Hospital Cancer Center and an instructor at Harvard Medical School since 2006.
He received a career development award from the National Cancer Institute and a Howard Hughes investigator award. He is an active member of the American Society of Clinical Oncology and American Association for Cancer Research.
The Wilmot Cancer Center is the Rochester and Finger Lakes region’s leader in cancer care and research.